Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Kolios_A NOT Kolios_AS:

Swiss S1 Guidelines on the Systemic Treatment of Psoriasis Vulgaris. Kolios AG et al. Dermatology. (2016)

Successful treatment of SAPHO syndrome with apremilast. Adamo S et al. Br J Dermatol. (2018)

[Not Available]. Kolios AG et al. Praxis (Bern 1994). (2016)

Search results

Items: 1 to 20 of 51

1.

Non-isothermal thermogravimetric kinetic analysis of the thermochemical conversion of human faeces.

Fidalgo B, Chilmeran M, Somorin T, Sowale A, Kolios A, Parker A, Williams L, Collins M, McAdam EJ, Tyrrel S.

Renew Energy. 2019 Mar;132:1177-1184. doi: 10.1016/j.renene.2018.08.090.

2.

Field testing of a prototype mechanical dry toilet flush.

Hennigs J, Ravndal KT, Blose T, Toolaram A, Sindall RC, Barrington D, Collins M, Engineer B, Kolios AJ, McAdam E, Parker A, Williams L, Tyrrel S.

Sci Total Environ. 2019 Jun 10;668:419-431. doi: 10.1016/j.scitotenv.2019.02.220. Epub 2019 Feb 17.

3.

IL-4 receptor engagement in human neutrophils impairs their migration and extracellular trap formation.

Impellizzieri D, Ridder F, Raeber ME, Egholm C, Woytschak J, Kolios AGA, Legler DF, Boyman O.

J Allergy Clin Immunol. 2019 Feb 12. pii: S0091-6749(19)30203-9. doi: 10.1016/j.jaci.2019.01.042. [Epub ahead of print]

PMID:
30768990
4.

Severe combined immunodeficiency (SCID) presenting in childhood, with agammaglobulinemia, associated with novel compound heterozygous mutations in DCLRE1C.

Sundin M, Marits P, Ramme K, Kolios AGA, Nilsson J.

Clin Immunol. 2019 Mar;200:16-18. doi: 10.1016/j.clim.2018.12.019. Epub 2019 Jan 7.

PMID:
30630113
5.

Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper.

Roth-Walter F, Adcock IM, Benito-Villalvilla C, Bianchini R, Bjermer L, Caramori G, Cari L, Chung KF, Diamant Z, Eguiluz-Gracia I, Knol EF, Kolios AGA, Levi-Schaffer F, Nocentini G, Palomares O, Puzzovio PG, Redegeld FA, van Esch BCAM, Stellato C.

Allergy. 2019 Mar;74(3):432-448. doi: 10.1111/all.13642. Epub 2019 Jan 8.

PMID:
30353939
6.

ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study.

Kolios AGA, Hueber AJ, Michetti P, Mrowietz U, Mustak-Blagusz M, Sator PG, Reinshagen M, Wilsmann-Theis D, Gomis-Kleindienst S, Luckey U, Rössler A, Schiefke I.

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):234-241. doi: 10.1111/jdv.15179. Epub 2018 Aug 22.

PMID:
29998520
7.

Thermodynamic analysis of a gamma type Stirling engine in an energy recovery system.

Sowale A, Kolios AJ, Fidalgo B, Somorin T, Parker A, Williams L, Collins M, McAdam E, Tyrrel S.

Energy Convers Manag. 2018 Jun 1;165:528-540. doi: 10.1016/j.enconman.2018.03.085.

8.

Conceptual environmental impact assessment of a novel self-sustained sanitation system incorporating a quantitative microbial risk assessment approach.

Anastasopoulou A, Kolios A, Somorin T, Sowale A, Jiang Y, Fidalgo B, Parker A, Williams L, Collins M, McAdam E, Tyrrel S.

Sci Total Environ. 2018 Oct 15;639:657-672. doi: 10.1016/j.scitotenv.2018.05.062. Epub 2018 May 26.

9.

Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects.

Schwab C, Gabrysch A, Olbrich P, Patiño V, Warnatz K, Wolff D, Hoshino A, Kobayashi M, Imai K, Takagi M, Dybedal I, Haddock JA, Sansom DM, Lucena JM, Seidl M, Schmitt-Graeff A, Reiser V, Emmerich F, Frede N, Bulashevska A, Salzer U, Schubert D, Hayakawa S, Okada S, Kanariou M, Kucuk ZY, Chapdelaine H, Petruzelkova L, Sumnik Z, Sediva A, Slatter M, Arkwright PD, Cant A, Lorenz HM, Giese T, Lougaris V, Plebani A, Price C, Sullivan KE, Moutschen M, Litzman J, Freiberger T, van de Veerdonk FL, Recher M, Albert MH, Hauck F, Seneviratne S, Pachlopnik Schmid J, Kolios A, Unglik G, Klemann C, Speckmann C, Ehl S, Leichtner A, Blumberg R, Franke A, Snapper S, Zeissig S, Cunningham-Rundles C, Giulino-Roth L, Elemento O, Dückers G, Niehues T, Fronkova E, Kanderová V, Platt CD, Chou J, Chatila TA, Geha R, McDermott E, Bunn S, Kurzai M, Schulz A, Alsina L, Casals F, Deyà-Martinez A, Hambleton S, Kanegane H, Taskén K, Neth O, Grimbacher B.

J Allergy Clin Immunol. 2018 Dec;142(6):1932-1946. doi: 10.1016/j.jaci.2018.02.055. Epub 2018 May 4.

PMID:
29729943
10.

Design and commissioning of a multi-mode prototype for thermochemical conversion of human faeces.

Jurado N, Somorin T, Kolios AJ, Wagland S, Patchigolla K, Fidalgo B, Parker A, McAdam E, Williams L, Tyrrel S.

Energy Convers Manag. 2018 May 1;163:507-524. doi: 10.1016/j.enconman.2018.02.065.

11.

Probabilistic performance assessment of complex energy process systems - The case of a self-sustained sanitation system.

Kolios A, Jiang Y, Somorin T, Sowale A, Anastasopoulou A, Anthony EJ, Fidalgo B, Parker A, McAdam E, Williams L, Collins M, Tyrrel S.

Energy Convers Manag. 2018 May 1;163:74-85. doi: 10.1016/j.enconman.2018.02.046.

12.

"Immune" Thrombocytopenia as Key Feature of a Novel ADA2 Deficiency Variant: Implication on Differential Diagnostics of ITP in Children.

Sundin M, Marits P, Nierkens S, Kolios AGA, Nilsson J.

J Pediatr Hematol Oncol. 2019 Mar;41(2):155-157. doi: 10.1097/MPH.0000000000001132.

PMID:
29620681
13.

Therapy response was not altered by HLA-Cw6 status in psoriasis patients treated with secukinumab: a retrospective case series.

Anzengruber F, Drach M, Maul JT, Kolios AG, Meier B, Navarini AA.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e274-e276. doi: 10.1111/jdv.14808. Epub 2018 Feb 27. No abstract available.

PMID:
29356172
14.

Clinical Disease Patterns in a Regional Swiss Cohort of 34 Pyoderma Gangrenosum Patients.

Kolios AGA, Gübeli A, Meier B, Maul JT, Kündig T, Nilsson J, Hafner J, Guenova E, Kerl K, Anliker M, Kempf W, Navarini AA, French LE, Cozzio A.

Dermatology. 2017;233(4):268-276. doi: 10.1159/000481432. Epub 2017 Nov 7.

15.

Successful treatment of SAPHO syndrome with apremilast.

Adamo S, Nilsson J, Krebs A, Steiner U, Cozzio A, French LE, Kolios AGA.

Br J Dermatol. 2018 Oct;179(4):959-962. doi: 10.1111/bjd.16071. Epub 2018 Mar 14.

16.

TNFα and IL-17A are differentially expressed in psoriasis-like vs eczema-like drug reactions to TNFα antagonists.

Deubelbeiss C, Kolios AGA, Anzengruber F, French LE, Yawalkar N, Kempf W, Kerl K, Meier B, Navarini AA.

J Cutan Pathol. 2018 Jan;45(1):23-28. doi: 10.1111/cup.13055. Epub 2017 Nov 22.

PMID:
29023827
17.

Late presenting atypical severe combined immunodeficiency (SCID) associated with a novel missense mutation in DCLRE1C.

Sundin M, Uhlin M, Gaballa A, Ramme K, Kolios AG, Marits P, Nilsson J.

Pediatr Allergy Immunol. 2018 Feb;29(1):108-111. doi: 10.1111/pai.12812. Epub 2017 Dec 12. No abstract available.

PMID:
28981982
18.

Faecal-wood biomass co-combustion and ash composition analysis.

Somorin TO, Kolios AJ, Parker A, McAdam E, Williams L, Tyrrel S.

Fuel (Lond). 2017 Sep 1;203:781-791. doi: 10.1016/j.fuel.2017.05.038.

19.

Comparison of pyoderma gangrenosum and Martorell hypertensive ischaemic leg ulcer in a Swiss cohort.

Kolios AGA, Hafner J, Luder C, Guenova E, Kerl K, Kempf W, Nilsson J, French LE, Cozzio A.

Br J Dermatol. 2018 Feb;178(2):e125-e126. doi: 10.1111/bjd.15901. Epub 2018 Jan 7. No abstract available.

20.

Cutaneous Corynebacterium Infection Presenting with Disseminated Skin Nodules and Ulceration.

Kolios AGA, Cozzio A, Zinkernagel AS, French LE, Kündig TM.

Case Rep Dermatol. 2017 May 16;9(2):8-12. doi: 10.1159/000476054. eCollection 2017 May-Aug.

Supplemental Content

Loading ...
Support Center